You can apply for a partnership grant to support new partnerships between diverse groups of researchers in the area of infections and immunity.
Funding is available for between one and five years to:
establish new, high-value collaborative activities and capabilities
add value to high-quality scientific programmes that are already supported by grants from MRC and other funders.
Who can apply
Any UK-based researcher with an employment contract at an eligible research organisation can apply. You will need to:
have at least a graduate degree, although we usually expect most applicants to have a PhD or medical degree
show that you will direct the partnership and be actively engaged in the work.
You can include one or more industry partners as project partners in your application. International co-investigators can be included if they provide expertise not available in the UK.
A principal investigator must lead the partnership. Any researchers you invite to become co-investigators must contribute to the academic leadership of the partnership.
What the MRC are looking for
The Infections and Immunity Board funds research into infectious human disease and disorders of the human immune system. The board supports a diverse portfolio of research of relevance to the UK and globally and to address both long-standing questions and support the investigation of emerging higher-risk opportunities.
Research they fund includes, but is not limited to, the following areas:
- discovery research relating to human pathogens, pathogenicity, antimicrobial resistance, host pathogen responses including inflammation and the development function and disorders of the immune system where this informs mechanism of disease. Immune disease including allergy (except asthma and other organ-based disorders), transplantation immunology, systemic immune disorders and auto-immune disease. Including use of in silico systems, relevant animal models and experimental studies in humans throughout the lifecourse
- population-level research, using epidemiological, genetic and omic approaches, and computational modelling to elucidate disease risks, aetiologies and progression, and to understand the evolution of pathogen populations and epidemic preparedness
- research to inform novel strategies for preventing and controlling infectious and immune disease, including vector control, predictive modelling and early development research to inform future intervention strategies including vaccines.